MedPath

Mazandaran University of Medical Sciences

Mazandaran University of Medical Sciences logo
Iran
Ownership
Private
Established
1988-01-01
Employees
-
Market Cap
-
Website
http://wwww.mazums.ac.ir

Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial

Not Applicable
Conditions
Coronavirus Infections
Interventions
Biological: Convalescent Plasma
First Posted Date
2020-03-31
Last Posted Date
2020-03-31
Lead Sponsor
Mazandaran University of Medical Sciences
Target Recruit Count
30
Registration Number
NCT04327349
Locations
🇮🇷

Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran, Islamic Republic of

Thrombolysis Outcome in Ischemic Stroke

Completed
Conditions
Mortality
Thrombolytic Therapy
Stroke, Acute
Alteplase
First Posted Date
2020-03-16
Last Posted Date
2020-07-09
Lead Sponsor
Mazandaran University of Medical Sciences
Target Recruit Count
214
Registration Number
NCT04309357
Locations
🇮🇷

Bu Ali Sina hospital , Mazandarn University of Medical Science, Sari, Iran, Islamic Republic of

Rituximab-Induced Hypogammaglobulinemia in Multiple Sclerosis

Conditions
Multiple Sclerosis
Hypogammaglobulinemia
First Posted Date
2020-02-25
Last Posted Date
2020-07-10
Lead Sponsor
Mazandaran University of Medical Sciences
Target Recruit Count
170
Registration Number
NCT04283747
Locations
🇮🇷

Bu Ali Sina hospital, Sari, Iran, Islamic Republic of

Rivaroxaban Plus ASA in Embolic Stroke of Undetermined Source(AREST-ESUS)

Phase 2
Completed
Conditions
Prevention
Stroke
Interventions
First Posted Date
2020-02-18
Last Posted Date
2023-10-19
Lead Sponsor
Mazandaran University of Medical Sciences
Target Recruit Count
42
Registration Number
NCT04273516
Locations
🇮🇷

Bou- Ali Sina Hospital, Sari, Mazandaran, Iran, Islamic Republic of

Trigger Point Massage in Chronic Tension Headache

Not Applicable
Completed
Conditions
Tension-Type Headache
Interventions
Other: Massage
First Posted Date
2020-01-18
Last Posted Date
2020-01-18
Lead Sponsor
Mazandaran University of Medical Sciences
Target Recruit Count
80
Registration Number
NCT04232046

Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures

Phase 4
Completed
Conditions
Epilepsy, Idiopathic Generalized
Interventions
First Posted Date
2019-05-07
Last Posted Date
2022-02-17
Lead Sponsor
Mazandaran University of Medical Sciences
Target Recruit Count
103
Registration Number
NCT03940326
Locations
🇮🇷

Bu Ali Sina Hospital, Sari, Mazandaran, Iran, Islamic Republic of

Evaluation of Memantine Versus Placebo on Ischemic Stroke Outcome

Phase 3
Completed
Conditions
Ischemic Stroke
Memantine
Excitotoxicity
Interventions
Drug: Placebo
First Posted Date
2015-08-28
Last Posted Date
2020-10-06
Lead Sponsor
Mazandaran University of Medical Sciences
Target Recruit Count
47
Registration Number
NCT02535611

Selenium and Ischemic Stroke Outcome

Not Applicable
Completed
Conditions
Ischemic Stroke
Interventions
Drug: normal saline
Dietary Supplement: Selenium
First Posted Date
2015-07-22
Last Posted Date
2020-01-27
Lead Sponsor
Mazandaran University of Medical Sciences
Target Recruit Count
44
Registration Number
NCT02505295
Locations
🇮🇷

Athena Sharifi Razavi, Sari, Mazandaran, Iran, Islamic Republic of

Vitamine D in Multiple Sclerosis

Phase 3
Conditions
Multiple Sclerosis
Interventions
Drug: Placebo
First Posted Date
2013-01-15
Last Posted Date
2013-01-15
Lead Sponsor
Mazandaran University of Medical Sciences
Target Recruit Count
240
Registration Number
NCT01768039
Locations
🇮🇷

Mazandaran University of medical sciences, Sari, Mazandaran, Iran, Islamic Republic of

Study of Zonisamide in Early Parkinson Disease

Phase 2
Withdrawn
Conditions
Parkinson Disease
Interventions
Drug: Placebo
First Posted Date
2013-01-11
Last Posted Date
2022-04-14
Lead Sponsor
Mazandaran University of Medical Sciences
Registration Number
NCT01766128
© Copyright 2025. All Rights Reserved by MedPath